Clinical Trial Update: Asia Myelodysplastic Syndrome (MDS) Registry

View source ↗

Summary

Asia-based registry study on myelodysplastic syndromes (MDS) sponsored by Bristol-Myers Squibb is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Myelodysplastic Syndromes (MDS) | Status: NOT_YET_RECRUITING